Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms

被引:24
作者
Besga, A. [1 ,7 ]
Cedazo-Minguez, A. [2 ]
Kareholt, I. [3 ]
Solomon, A. [3 ,4 ]
Bjorkhem, I. [5 ]
Winblad, B. [2 ]
Leoni, V. [6 ]
Hooshmand, B. [3 ]
Spulber, G. [2 ]
Gonzalez-Pinto, A. [1 ,7 ]
Kivipelto, M. [3 ,4 ]
Wahlund, L. O. [2 ]
机构
[1] Hosp Univ Alava, Dept Psychiat, Vitoria, Spain
[2] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
[3] Stockholm Univ, Aging Res Ctr, Karolinska Inst, S-10691 Stockholm, Sweden
[4] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland
[5] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-10401 Stockholm, Sweden
[6] Natl Inst Neurol C Besta, Lab Clin Pathol & Med Genet, Milan, Italy
[7] Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain
关键词
Alzheimer disease; Cholesterol; Oxysterols; Hyperintensities; A beta 42; Tau; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; HYPERINTENSITIES; OXYSTEROLS; PROTEINS; MRI;
D O I
10.1016/j.neulet.2012.01.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Investigate possible associations of white matter hyperintensities (WMHs) with the metabolism of cholesterol and insulin in two subgroups of patients with memory complaints and different CSF A beta 42 and CSF tau levels. 59 patients from the memory clinic at Karolinska Hospital were included. Degree of WMHs was rated using the ARWMC scale and the following biomarkers were measured in CSF and plasma: insulin, cholesterol, lanosterol, lathosterol, and oxidized cholesterol metabolites. The WMHs in CSF control-like group correlated with increased brain cholesterol synthesis and reduced efflux of oxysterols and insulin in CSF. In the CSF AD-like group, the WMHs correlated with increased peripheral cholesterol metabolism. Despite having similar appearance on FLAIR images, the pathogenic mechanisms of WMHS are likely to be different in the two groups investigated. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 16 条
[1]   Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease [J].
Andreasen, N ;
Hesse, C ;
Davidsson, P ;
Minthon, L ;
Wallin, A ;
Winblad, B ;
Vanderstichele, H ;
Vanmechelen, E ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 1999, 56 (06) :673-680
[2]   Crossing the barrier:: oxysterols as cholesterol transporters and metabolic modulators in the brain [J].
Bjorkhem, I. .
JOURNAL OF INTERNAL MEDICINE, 2006, 260 (06) :493-508
[3]  
Dorszewska J, 1997, FOLIA NEUROPATHOL, V35, P115
[4]   PATHOLOGICAL CORRELATES OF INCIDENTAL MRI WHITE-MATTER SIGNAL HYPERINTENSITIES [J].
FAZEKAS, F ;
KLEINERT, R ;
OFFENBACHER, H ;
SCHMIDT, R ;
KLEINERT, G ;
PAYER, F ;
RADNER, H ;
LECHNER, H .
NEUROLOGY, 1993, 43 (09) :1683-1689
[5]   Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease [J].
Frölich, L ;
Blum-Degen, D ;
Bernstein, HG ;
Engelsberger, S ;
Humrich, J ;
Laufer, S ;
Muschner, D ;
Thalheimer, A ;
Türk, A ;
Hoyer, S ;
Zöchling, R ;
Boissl, KW ;
Jellinger, K ;
Riederer, P .
JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (4-5) :423-438
[6]   In vivo insulin deficiency as a potential etiology for demyelinating disease [J].
Gong, Xiaoming ;
Xie, Zuoping ;
Zuo, Huancong .
MEDICAL HYPOTHESES, 2008, 71 (03) :399-403
[7]   Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging [J].
Holland, Christopher M. ;
Smith, Eric E. ;
Csapo, Istvan ;
Gurol, Mahmut Edip ;
Brylka, Douglas A. ;
Killiany, Ronald J. ;
Blacker, Deborah ;
Albert, Marilyn S. ;
Guttmann, Charles R. G. ;
Greenberg, Steven M. .
STROKE, 2008, 39 (04) :1127-1133
[8]   Alterations of cholesterol precursor levels in Alzheimer's disease [J].
Koelsch, Heike ;
Heun, Reinhard ;
Jessen, Frank ;
Popp, Julius ;
Hentschel, Frank ;
Maier, Wolfgang ;
Luetjohann, Dieter .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (08) :945-950
[9]   Diagnostic use of cerebral and extracerebral oxysterols [J].
Leoni, V ;
Masterman, T ;
Mousavi, FS ;
Wretlind, B ;
Wahlund, LO ;
Diczfalusy, U ;
Hillert, J ;
Björkhem, I .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (02) :186-191
[10]   Increased Aβ peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease [J].
Roher, AE ;
Weiss, N ;
Kokjohn, TA ;
Kuo, YM ;
Kalback, W ;
Anthony, J ;
Watson, D ;
Luehrs, DC ;
Sue, L ;
Walker, D ;
Emmerling, M ;
Goux, W ;
Beach, T .
BIOCHEMISTRY, 2002, 41 (37) :11080-11090